Novel oral anticoagulants (TSOACs) have been developed and found to be at least non-inferior to VKAs with regards to efficacy but the risk of bleeding with TSOACs remains controversial. A total of 12 RCTs involving 102,607 patients were retrieved. TSOACs significantly reduced the risk of overall …

READ FULL ARTICLE Curated publisher From www.bloodjournal.org